Atlas Trials

Verification of the Efficacy/safety of the Intratympanic Drug Delivery for Hearing Loss

Clinical trial NCT04766853 · COMPLETED

Trial details

NCT number
NCT04766853
Sponsor
Seoul National University Hospital
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Hearing Loss, SuddenHearing Loss, OtotoxicHearing Loss, Noise-InducedMeniere Disease
Start date
2021-07-22
Primary completion
2023-04-18
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.